Technetium-99m-Sestamibi Uptake in Breast Tumor and Associated Lymph Nodes

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 922-925

  Maublant, Jean ^a   De Latour, Monique ^b   Mestas, Daniéle ^b   Clemenson, Alix ^b   Charrier, Sabine ^b   Feillel, Viviane ^b   Le Bouedec, Guillaume ^b   Kaufmann, Philippe ^b   Dauplat, Jacques ^b   Veyre, Annie ^b  

^a CENTRE JEAN PERRIN   (France)

^b NONE

Author keywords

Breast tumors; Lymph nodes; Technetium 99m sestamibi

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; AXILLA; BREAST TUMOR; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE; MALE; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030163021     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chia ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (1) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.
2. Songadele JA, Younès A, Maublant J, Meunier JP, Veyre A. Direct demonstration of the mitochondrial uptake of Tc-99m-sestamibi [Abstract]. J Nucl Cardiol 1995;2:S68.
3. Delmon-Moigeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL. Uptake of the cation hexakis (2-methoxyisobulyl-isonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990;50:2198-2202.
4. Maublant J, Zhang Z, Rapp M, et al. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34:1949-1952.
5. Hassan IM, Sahweil A, Milroy R, et al. Uptake and kinetics of Tc-99m-hexakis-2-methoxy-isobutyl-isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
6. O'Tuama LA, Packard AR, Treves SD. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 1990;31:2040-2041.
7. Caner B, Kitapçi M, Aras T, et al. Increased accumulation of hexakis (2-methoxyisobulylisonitrile) technetium (I) in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991;32:1977-1978.
8. Aktolun C, Bayhan H, Celasum B, Kir MK. Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease). Eur J Nucl Med 1991;18:856-859.
9. Caner B, Kitapçl M, Unlu M, et al. Technetium-99m-MIBI uptake in benign and maligant bone lesions: a comparative study with technctium-99m-MDP. J Nucl Med 1992;33:319-324.
10. Balon HR, Fink-Bennett D, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med 1992;33:1393-1395.
11. Scott AM, Kostakoglu, O'Brien JP, et al. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992;33:1396-1398.
12. Baillet G, Albuquerque L, Chen Q, et al. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1992;21:1061-1066.
13. Khalkhali I, Mena I, Jouanne R, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994:178:491-497.
14. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:1-8.
15. Verrelle P, Meissonnier F, Fonek Y, et al. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 1991;83:111-116.